| Reference |
|---|
Duan L, Ma Y, Reisch B, Hadrovic E, Mach P, Kimmig R, et al. Alteration in sB7-H4 Serum Levels and Placental Biomarker Expression after Therapeutic Plasma Exchange in Early-Onset Preeclampsia Patients. Int J Mol Sci. 2024;25: pubmed publisher |
Pintye D, Sziva R, Mastyugin M, Young B, Jacas S, T xf6 r xf6 k M, et al. A Novel Dual-Function Redox Modulator Relieves Oxidative Stress and Anti-Angiogenic Response in Placental Villus Explant Exposed to Hypoxia-Relevance for Preeclampsia Therapy. Biology (Basel). 2023;12: pubmed publisher |
Yang Z, Jia X, Deng Q, Luo M, Hou Y, Yue J, et al. Human umbilical cord mesenchymal stem cell-derived extracellular vesicles loaded with TFCP2 activate Wnt/β-catenin signaling to alleviate preeclampsia. Int Immunopharmacol. 2023;115:109732 pubmed publisher |
Dymara Konopka W, Laskowska M, Grywalska E, Hymos A, B x142 a x17c ewicz A, Leszczy x144 ska Gorzelak B. Similar Pro- and Antiangiogenic Profiles Close to Delivery in Different Clinical Presentations of Two Pregnancy Syndromes: Preeclampsia and Fetal Growth Restriction. Int J Mol Sci. 2023;24: pubmed publisher |
Haarmann A, Vollmuth C, Kollikowski A, Heuschmann P, Pham M, Stoll G, et al. Vasoactive Soluble Endoglin: A Novel Biomarker Indicative of Reperfusion after Cerebral Large-Vessel Occlusion. Cells. 2023;12: pubmed publisher |
Ryu G, Kim Y, Lee K, Choi S, Hong S, Jung Y, et al. Obstructive Sleep Apnea Is Associated With Late-Onset Preeclampsia in Overweight Pregnant Women in Korea. J Korean Med Sci. 2023;38:e8 pubmed publisher |
Abascal Saiz A, Duque Alcorta M, Fioravantti V, Antol xed n E, Fuente Luelmo E, Haro M, et al. The Relationship between Angiogenic Factors and Energy Metabolism in Preeclampsia. Nutrients. 2022;14: pubmed publisher |
Anto E, Coall D, Asiamah E, Afriyie O, Addai Mensah O, Wiafe Y, et al. Placental lesions and differential expression of pro-and anti-angiogenic growth mediators and oxidative DNA damage marker in placentae of Ghanaian suboptimal and optimal health status pregnant women who later developed preeclampsia. PLoS ONE. 2022;17:e0265717 pubmed publisher |
Nejmanov xe1 I, Vitverov xe1 B, Eissazadeh S, Tripsk xe1 K, Igreja Sa I, Hy x161 pler R, et al. High Soluble Endoglin Levels Affect Aortic Vascular Function during Mice Aging. J Cardiovasc Dev Dis. 2021;8: pubmed publisher |
Ruiz Llorente L, Vega M, Fernandez F, Langa C, Morrell N, Upton P, et al. Generation of a Soluble Form of Human Endoglin Fused to Green Fluorescent Protein. Int J Mol Sci. 2021;22: pubmed publisher |
Pérez Roque L, Núñez Gómez E, Rodriguez Barbero A, Bernabeu C, Lopez Novoa J, Pericacho M. Pregnancy-Induced High Plasma Levels of Soluble Endoglin in Mice Lead to Preeclampsia Symptoms and Placental Abnormalities. Int J Mol Sci. 2020;22: pubmed publisher |
Kim S, Park M, Kim J, Kim T, Hwang J, Ha K, et al. Circulating miRNAs Associated with Dysregulated Vascular and Trophoblast Function as Target-Based Diagnostic Biomarkers for Preeclampsia. Cells. 2020;9: pubmed publisher |
Polster S, Sharma A, Tanes C, Tang A, Mericko P, Cao Y, et al. Permissive microbiome characterizes human subjects with a neurovascular disease cavernous angioma. Nat Commun. 2020;11:2659 pubmed publisher |
Wilson D, Howard M, Fung A, O Donoghue F, Barnes M, Lappas M, et al. Sleep-disordered breathing does not impact maternal outcomes in women with hypertensive disorders of pregnancy. PLoS ONE. 2020;15:e0232287 pubmed publisher |
Gallardo Vara E, Gamella Pozuelo L, Pérez Roque L, Bartha J, García Palmero I, Casal J, et al. Potential Role of Circulating Endoglin in Hypertension via the Upregulated Expression of BMP4. Cells. 2020;9: pubmed publisher |
Rahman R, Murthi P, Singh H, Gurungsinghe S, Leaw B, Mockler J, et al. Hydroxychloroquine Mitigates the Production of 8-Isoprostane and Improves Vascular Dysfunction: Implications for Treating Preeclampsia. Int J Mol Sci. 2020;21: pubmed publisher |
Aristorena M, Gallardo Vara E, Vicen M, de Las Casas Engel M, Ojeda Fernandez L, Nieto C, et al. MMP-12, Secreted by Pro-Inflammatory Macrophages, Targets Endoglin in Human Macrophages and Endothelial Cells. Int J Mol Sci. 2019;20: pubmed publisher |
Unger H, Hansa A, Buffet C, Hasang W, Teo A, Randall L, et al. Sulphadoxine-pyrimethamine plus azithromycin may improve birth outcomes through impacts on inflammation and placental angiogenesis independent of malarial infection. Sci Rep. 2019;9:2260 pubmed publisher |
Li H, Yao J, Chang X, Wu J, Duan T, Wang K. LIFR increases the release of soluble endoglin via the upregulation of MMP14 expression in preeclampsia. Reproduction. 2018;155:297-306 pubmed publisher |
Ruiz Remolina L, Ollauri Ibáñez C, Pérez Roque L, Núñez Gómez E, Perez Barriocanal F, Lopez Novoa J, et al. Circulating soluble endoglin modifies the inflammatory response in mice. PLoS ONE. 2017;12:e0188204 pubmed publisher |
O Brien M, Baczyk D, Kingdom J. Endothelial Dysfunction in Severe Preeclampsia is Mediated by Soluble Factors, Rather than Extracellular Vesicles. Sci Rep. 2017;7:5887 pubmed publisher |
Blaha V, Blaha M, Lanska M, Solichova D, Kujovska Krcmova L, Havel E, et al. Lipoprotein apheresis in the treatment of dyslipidaemia - the Czech Republic experience. Physiol Res. 2017;66:S91-S100 pubmed |
Saita E, Miura K, Suzuki Sugihara N, Miyata K, Ikemura N, Ohmori R, et al. Plasma Soluble Endoglin Levels Are Inversely Associated With the Severity of Coronary Atherosclerosis-Brief Report. Arterioscler Thromb Vasc Biol. 2017;37:49-52 pubmed publisher |
Weel I, Baergen R, Romão Veiga M, Borges V, Ribeiro V, Witkin S, et al. Association between Placental Lesions, Cytokines and Angiogenic Factors in Pregnant Women with Preeclampsia. PLoS ONE. 2016;11:e0157584 pubmed publisher |
Nemeckova I, Serwadczak A, Oujo B, Ježková K, Rathouska J, Fikrová P, et al. High soluble endoglin levels do not induce endothelial dysfunction in mouse aorta. PLoS ONE. 2015;10:e0119665 pubmed publisher |
White W, Garrett A, Craici I, Wagner S, Fitz Gibbon P, Butters K, et al. Persistent urinary podocyte loss following preeclampsia may reflect subclinical renal injury. PLoS ONE. 2014;9:e92693 pubmed publisher |
Rana S, Cerdeira A, Wenger J, Salahuddin S, Lim K, Ralston S, et al. Plasma concentrations of soluble endoglin versus standard evaluation in patients with suspected preeclampsia. PLoS ONE. 2012;7:e48259 pubmed publisher |
Widemann B, Kim A, Fox E, Baruchel S, Adamson P, Ingle A, et al. A phase I trial and pharmacokinetic study of sorafenib in children with refractory solid tumors or leukemias: a Children's Oncology Group Phase I Consortium report. Clin Cancer Res. 2012;18:6011-22 pubmed publisher |
Kaitu u Lino T, Palmer K, Tuohey L, Ye L, Tong S. MMP-15 is upregulated in preeclampsia, but does not cleave endoglin to produce soluble endoglin. PLoS ONE. 2012;7:e39864 pubmed publisher |
Silver K, Conroy A, Leke R, Leke R, Gwanmesia P, Molyneux M, et al. Circulating soluble endoglin levels in pregnant women in Cameroon and Malawi--associations with placental malaria and fetal growth restriction. PLoS ONE. 2011;6:e24985 pubmed publisher |
Landt S, Mordelt K, Schwidde I, Barinoff J, Korlach S, Stöblen F, et al. Prognostic significance of the angiogenic factors angiogenin, endoglin and endostatin in cervical cancer. Anticancer Res. 2011;31:2651-5 pubmed |
DuBois S, Shusterman S, Ingle A, Ahern C, Reid J, Wu B, et al. Phase I and pharmacokinetic study of sunitinib in pediatric patients with refractory solid tumors: a children's oncology group study. Clin Cancer Res. 2011;17:5113-22 pubmed publisher |
Jeyabalan A, Powers R, Clifton R, Van Dorsten P, Hauth J, Klebanoff M, et al. Effect of smoking on circulating angiogenic factors in high risk pregnancies. PLoS ONE. 2010;5:e13270 pubmed publisher |
Powers R, Jeyabalan A, Clifton R, Van Dorsten P, Hauth J, Klebanoff M, et al. Soluble fms-Like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies. PLoS ONE. 2010;5:e13263 pubmed publisher |
Santner Nanan B, Peek M, Khanam R, Richarts L, Zhu E, Fazekas de St Groth B, et al. Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia. J Immunol. 2009;183:7023-30 pubmed publisher |
Chen Y, Hao Q, Kim H, Su H, Letarte M, Karumanchi S, et al. Soluble endoglin modulates aberrant cerebral vascular remodeling. Ann Neurol. 2009;66:19-27 pubmed publisher |
Blankley R, Gaskell S, Whetton A, Dive C, Baker P, Myers J. A proof-of-principle gel-free proteomics strategy for the identification of predictive biomarkers for the onset of pre-eclampsia. BJOG. 2009;116:1473-80 pubmed publisher |
Shariat S, Karam J, Walz J, Roehrborn C, Montorsi F, Margulis V, et al. Improved prediction of disease relapse after radical prostatectomy through a panel of preoperative blood-based biomarkers. Clin Cancer Res. 2008;14:3785-91 pubmed publisher |
Svatek R, Karam J, Roehrborn C, Karakiewicz P, Slawin K, Shariat S. Preoperative plasma endoglin levels predict biochemical progression after radical prostatectomy. Clin Cancer Res. 2008;14:3362-6 pubmed publisher |
Karam J, Svatek R, Karakiewicz P, Gallina A, Roehrborn C, Slawin K, et al. Use of preoperative plasma endoglin for prediction of lymph node metastasis in patients with clinically localized prostate cancer. Clin Cancer Res. 2008;14:1418-22 pubmed publisher |
Levine R, Lam C, Qian C, Yu K, Maynard S, Sachs B, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med. 2006;355:992-1005 pubmed |
Furstenberger G, von Moos R, Lucas R, Thurlimann B, Senn H, Hamacher J, et al. Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer. Br J Cancer. 2006;94:524-31 pubmed |
